Physician profile
Sonia Bennett
NPI 1265826192
$2,885.78
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $447 · 2021: $1,800 · 2022: $478 · 2023: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $461.85 | 2020-2022 | |
| Amgen INC. | $378.91 | 2020-2022 | |
| Novo Nordisk INC | $255.97 | 2020-2022 | |
| Dexcom, INC. | $222.40 | 2021-2023 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $178.12 | 2020-2023 | Korlym |
| Abbott Laboratories | $170.21 | 2021-2022 | |
| Pfizer INC. | $156.40 | 2020-2022 | |
| Amarin Pharma, INC. | $134.06 | 2020-2022 | |
| Radius Health, INC. | $106.84 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $96.57 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $82.41 | 2020-2022 | |
| Abbvie INC. | $79.40 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $71.75 | 2020-2022 | |
| Antares Pharma, INC. | $65.90 | 2021-2022 | |
| Clarus Therapeutics INC. | $58.88 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $46.94 | 2021-2023 | Omnipod |
| Takeda Pharmaceuticals U.S.A., INC. | $40.99 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.64 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $36.89 | 2022 | |
| Ibsa Pharma INC. | $36.48 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $24.96 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $24.85 | 2021 | |
| Eisai INC. | $24.67 | 2020 | |
| Novartis Pharmaceuticals Corporation | $20.88 | 2022 | |
| Sk Life Science, INC. | $19.94 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.61 | 2021 | |
| Amryt Pharma Holdings LTD | $16.81 | 2022 | |
| Horizon Therapeutics Plc | $15.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.